Clarivate?Acquires?Bioinfogate, Reinforcing Position as Premier Provider of?End-to-End Research Intelligence Solutions for Life Sciences

(1)
Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customers to make more informed decisions?
LONDON, Aug. 4, 2021 /PRNewswire/ -- Clarivate Plc?(NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X?portal.?Financial terms of the transaction were not disclosed.??
The?Bioinfogate?OFF-X?portal is a cutting-edge safety intelligence solution aimed at empowering pharmaceutical organizations to identify toxicology and safety signals, mitigate safety liabilities and de-risk early-stage assets. It is one of the largest?translational safety and toxicity?portals, featuring over 1,200,000 safety alerts corresponding to over 23,000 drugs and biologics and more than 15,000 targets of pharmacological interest.??

Related Keywords

London ,City Of ,United Kingdom ,Tabita Seagrave ,Mark Donohue ,David Prous ,Mukhtar Ahmed ,Prous Institute For Biomedical Research ,Exchange Commission ,Thomson Reuters ,Science Group ,Prnewswire Clarivate Plc ,Decision Resources Group ,Head Of Global Corporate Communications ,Cortellis Drug Discovery Intelligence ,Prous Science ,Cortellis Drug Discovery ,Cortellis Competitive ,Executive Director ,Prous Institute ,Biomedical Research ,Private Securities Litigation Reform Act ,Global Corporate ,லண்டன் ,நகரம் ஆஃப் ,ஒன்றுபட்டது கிஂக்டம் ,குறி தோனொுே ,பரிமாற்றம் தரகு ,தாம்சன் ராய்ட்டர்ஸ் ,அறிவியல் குழு ,முடிவு வளங்கள் குழு ,தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் ,நிர்வாகி இயக்குனர் ,உயிர் மருத்துவ ஆராய்ச்சி ,ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,உலகளாவிய பெருநிறுவன ,